Evidence map›Paper›PMID 29808386›Full record

Observational studyThe international journal of cardiovascular imaging2018

Prognostic value of revascularising viable myocardium in elderly patients with stable coronary artery disease and left ventricular dysfunction: a PET/CT study.

Mehdi Namdar, Olivier Rager, Julien Priamo, Angela Frei, Stephane Noble, Gael Amzalag, Osman Ratib, René Nkoulou

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in The international journal of cardiovascular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The predictive value ofThe international journal of cardiovascular imaging · 2026
    Article
  2. Review
  3. Cardiovascular imaging 2018 in the International Journal of Cardiovascular Imaging.The international journal of cardiovascular imaging · 2019
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mehdi NamdarDivision of Cardiology, University Hospital Geneva, Geneva, Switzerland.
Olivier RagerDivision of Nuclear Medicine, University Hospital Geneva, Geneva, Switzerland.
Julien PriamoDivision of Internal Medicine, University Hospital Geneva, Geneva, Switzerland.
Angela FreiDivision of Cardiology, University Hospital Geneva, Geneva, Switzerland.
Stephane NobleDivision of Cardiology, University Hospital Geneva, Geneva, Switzerland.
Gael AmzalagDivision of Nuclear Medicine, University Hospital Geneva, Geneva, Switzerland.
Osman RatibDivision of Nuclear Medicine, University Hospital Geneva, Geneva, Switzerland.
René NkoulouDivision of Cardiology, University Hospital Geneva, Geneva, Switzerland. rene.nkoulou@hcuge.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sparse information is available on the role of cardiac viability imaging in elderly patients. We aimed at evaluating the prognostic value of FDG-PET/CT in elderly patients with stable coronary artery disease (CAD) and reduced left ventricular ejection fraction (rLVEF) before revascularisation. Elderly patients (> 65 years old, mean 74 ± 7 years old) with CAD and rLVEF were followed after cardiac FDG-PET/CT and stratified according to presence/absence of viable myocardium and subsequent revascularisation. Fatal events of any cause as well as hospitalisations related to acute cardiac conditions were reported as clinical end-points. Predictors of fatal events in patients with viable myocardium (> 1 myocardium segment/20) were analysed. A total of 89 patients were followed (64 viable myocardia; 37 and 27 patients with and without subsequent revascularisation, respectively). The change in LVEF during follow-up (2.1 ± 1.6 years) was 3.8 ± 6.6% (P = 0.013) and - 0.75 ± 2.6% (P = 0.170) in patients with and without revascularisation, respectively. Log-rank (P = 0.037) and multivariate analysis (Wald: 6.305, P = 0.012) showed viable myocardium to be significantly associated with fatal events if not revascularised. Elderly patients with viable myocardium might potentially benefit from revascularisation procedures as improved left ventricular ejection fraction and survival were observed in our retrospective study as compared to patients in whom a revascularisation procedure was denied. Viable myocardium as detected by cardiac FDG PET/CT was associated with better clinical outcomes in elderly patients when revascularised.

Indexed as

AgedAged, 80 and overCoronary Artery DiseaseFemaleFluorodeoxyglucose F18HumansMaleMyocardial RevascularizationMyocardiumPositron Emission Tomography Computed TomographyPredictive Value of TestsPrognosisRadiopharmaceuticalsRetrospective StudiesVentricular Dysfunction, LeftFluorodeoxyglucose F18RadiopharmaceuticalsCardiacElderlyPET/CTViability imaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.